Jiming Zhou
CIK: 0002109760
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AIDX
20/20 Biolabs, Inc.
Officer
Discretionary Trading P&L
Holdings
About Zhou Jiming
Zhou Jiming (SEC CIK 0002109760) files insider reports with the SEC as Chief Operating Officer of 20/20 Biolabs, Inc. (AIDX).
Signal8 holds 2 ownership filings by Zhou Jiming (1 Form 3, 1 Form 4), filed between Feb 17, 2026 and Apr 6, 2026. Those filings report 1 transaction, the latest on Apr 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Zhou Jiming's filings is in GAITHERSBURG, MD.
Recent filings by Zhou Jiming
- Apr 2, 2026: Grant or award of AIDX derivative securities (Form 4, code A).
Other insiders filing for 20/20 Biolabs, Inc. (AIDX)
- Bergman Alan B., Chief Financial Officer
- Cohen Jonathan M, Chief Executive Officer
- Rollins John Woodson, Director
- Ross Michael A., Director
- Compton John G., Director
- COHEN RICHARD M, Director